The Advocate General has delivered her advisory opinion on questions referred to the European Court of Justice seeking clarification on the conditions for obtaining supplementary protection certificates (“SPCs”) for medicinal products marketed in EU Member States.
Downloads –
Related Capabilities
Practices –
Industries –
Latest Perspectives
-
April 122021
Stay up-to-date on our perspectives
Subscribe to Email